Table 3.
Summary of the positive results obtained by each assay to detect the presence of HEV among non-A-C hepatitis patients in Qatar (n = 259)
| HEV marker | No. positive (%) | Total no. of ALT tested specimen | Sample no. with normal ALT (%) | Sample no. with an elevated ALT (%) |
|---|---|---|---|---|
| Wantai-IgM | 20 (8.65) | 17 | 2/17 (11.8) | 15/17 (88.2) |
| Wantai HEV-IgG | 74 (32.1) | 69 | 17/69 (24.6) | 51/69 (73.9) |
| Wantai HEV-Ag | 10 (5.56) | 8 | 0 (0) | 8/8 (100) |
| MP HEV-Total Ab | 53 (34.2) | 49 | 13 (26.5) | 36/49 (37.5) |
| RT-PCR HEV-RNA | 24 (23.1) | 19 | 1 (5.3) | 18/19 (94.7) |
ALT test was not done in all samples due to insufficient volume